These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34756420)

  • 1. Re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.CCR-20-1876.
    Funada S; Yoshioka T; Luo Y
    Eur Urol Oncol; 2020 Oct; ():. PubMed ID: 34756420
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3.
    Funada S; Yoshioka T; Luo Y
    Eur Urol; 2020 Dec; 78(6):e225-e226. PubMed ID: 32958297
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3.
    Hopkins AM; Kichenadasse G; Sorich MJ
    Eur Urol; 2020 Dec; 78(6):e227. PubMed ID: 32958298
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, et al. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.ccr-20-2063.
    Rizzo A; Mollica V; Massari F
    Eur Urol Oncol; 2020 Dec; 3(6):804-805. PubMed ID: 33121939
    [No Abstract]   [Full Text] [Related]  

  • 5. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H; Wassie E; Alsharedi M
    Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
    Gil M; Ramil F; AgÍs JA
    Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab.
    Tomisaki I; Harada M; Sakano S; Terado M; Hamasuna R; Harada S; Matsumoto H; Akasaka S; Nagata Y; Minato A; Harada KI; Fujimoto N
    Int J Urol; 2023 Sep; 30(9):738-745. PubMed ID: 36693764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab.
    Fukuokaya W; Egawa S
    Eur Urol; 2021 Apr; 79(4):553-554. PubMed ID: 33277082
    [No Abstract]   [Full Text] [Related]  

  • 9. First report of the NA2 clonal lineage of the sudden oak death pathogen,
    Peterson EK; Sondreli KL; Reeser P; Navarro SM; Nichols C; Wiese R; Fieland V; Grünwald NJ; LeBoldus JM
    Plant Dis; 2022 Feb; ():. PubMed ID: 35147452
    [No Abstract]   [Full Text] [Related]  

  • 10. First Report of Root Rot of Tobacco Caused by Fusarium brachygibbosum in China.
    Qiu R; Li J; Zheng W; Su X; Xing G; Li S; Zhang Z; Li C; Wang J; Chen Y; Bai J; Zhao J; Ping WL
    Plant Dis; 2021 May; ():. PubMed ID: 34003036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036.
    Ayubi E; Safiri S
    Eur Urol; 2017 Dec; 72(6):e157. PubMed ID: 28576506
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
    Mezei G; Chang ET; Mowat FS; Moolgavkar SH
    Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Report of
    Serrato-Diaz LM; Aviles-Noriega A; Rivera-Vargas LI; Goenaga R
    Plant Dis; 2023 Jul; ():. PubMed ID: 37522876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Report of
    Anisimova OK; Seredin TM; Danilova OA; Filyushin M
    Plant Dis; 2021 Apr; ():. PubMed ID: 33835829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.
    Trock BJ; Karnes RJ
    Eur Urol; 2017 Dec; 72(6):e158-e159. PubMed ID: 28576503
    [No Abstract]   [Full Text] [Related]  

  • 17. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
    Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
    Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab.
    Hopkins AM; Kichenadasse G; Karapetis CS; Rowland A; Sorich MJ
    Clin Cancer Res; 2020 Oct; 26(20):5487-5493. PubMed ID: 32933995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Report of Root-Knot Nematode (
    Gao J; Zhao W; Qin Z; Chen L; Li M; Zhang J; Yang Q
    Plant Dis; 2023 Mar; ():. PubMed ID: 36935385
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy.
    Liedberg F; Abrahamsson J; Bobjer J
    Eur Urol; 2022 Jan; 81(1):e18-e19. PubMed ID: 34716048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.